An estimated 4.8 million people in the United States had opioid use disorder in 2024, the second most common drug use disorder after cannabis (SAMHSA NSDUH). Yet only about one in five US adults with OUD received any medication for the condition in the most recently reported year, even though medications for opioid use disorder are the single most effective treatment available (NIDA). The Stepwell Center treats OUD as the clinical condition it is, with a written plan, named modalities, and the medication options that fit your case, alongside the other substance use conditions we cover.
Recognition is rarely a single moment. Use that began with a prescription has shifted to higher doses or shorter intervals between refills, or use that began illicitly has become a daily organizing pressure. Tolerance has built, withdrawal has appeared between doses, work and family life have started to bend around the pattern, and prior attempts to stop have not held. The clinical definition follows that picture. OUD is diagnosed when at least two of eleven criteria appear in a twelve-month period, with severity rated mild, moderate, or severe (NIDA). Outpatient care is appropriate across that range when the assessment indicates the level of structure that fits.
Your plan begins with a 2 to 3 day comprehensive assessment that integrates clinical interview, qEEG brain mapping, pharmacogenetic testing when medication is on the table, and standardized psychological testing. The output is a written care plan that names the modalities, the medication considerations including the FDA-approved options for OUD, and the level of care that fits your clinical profile. The plan is delivered across PHP, IOP, Evening IOP, and Outpatient at our Lakeway, Texas facility in the Lake Travis corridor, by the same clinical team across each step.